Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

NCT00293176 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00293176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One-Year, Multicenter, Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
Lead sponsor
Eisai Inc.
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2003
Completion date
March 31, 2007
Enrollment
821 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

memory loss